Open-label extension trial of the safety and tolerability of OROSO methylphenidate in adults with ADHD - the long-acting methylphenidate in adult ADHD (lamda) trial

被引：0
|
作者：
Kooij, S.
Medori, R.
Buitelaar, J.
Ramos-Quiroga, J. A.
Lee, E.
Casas, M.
机构：
来源：
JOURNAL OF NEURAL TRANSMISSION | 2007年 / 114卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：XCIII / XCIII
页数：1
相关论文
共 50 条
  • [41] ADHD treatment with once-daily OROS methylphenidate: Final results from a long-term open-label study
    Wilens, T
    McBurnett, K
    Stein, M
    Lerner, M
    Spencer, T
    Wolraich, M
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (10): : 1015 - 1023
  • [42] Reboxetine for ADHD in children non-responders or with poor tolerance to methylphenidate: a prospective long-term open-label study
    Quintero, Javier
    Lopez-Munoz, Francisco
    Alamo, Cecilio
    Loro, Mercedes
    Garcia-Campos, Natalia
    ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS, 2010, 2 (03) : 107 - 113
  • [43] The effect of methylphenidate intake on brain structure in adults with ADHD in a placebo-controlled randomized trial
    van Elst, Ludger Tebartz
    Maier, Simon
    Kloeppel, Stefan
    Graf, Erika
    Killius, Carola
    Rump, Marthe
    Sobanski, Esther
    Ebert, Dieter
    Berger, Mathias
    Warnke, Andreas
    Matthies, Swantje
    Perlov, Evgeniy
    Philipsen, Alexandra
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2016, 41 (06): : 422 - 430
  • [44] Efficacy of prolonged-release methylphenidate in a randomized controlled trial in adults with ADHD: secondary endpoints
    Schaeuble, B.
    Orman, C.
    Palumbo, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S679 - S680
  • [45] Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy
    Punja, Salima
    Zorzela, Liliane
    Hartling, Lisa
    Urichuk, Liana
    Vohra, Sunita
    BMJ OPEN, 2013, 3 (03):
  • [46] Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial
    Cutler, Andrew J.
    Kalali, Amir H.
    Mattingly, Greg W.
    Kunovac, Jelena
    Meng, Xiangyi
    CNS SPECTRUMS, 2013, 18 (01) : 43 - 54
  • [47] Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate
    Williams, Erika D.
    Reimherr, Frederick W.
    Marchant, Barrie K.
    Strong, Robert E.
    Halls, Corinne
    Soni, Poonam
    Gale, Phillip D.
    Robison, Reid J.
    ANNALS OF CLINICAL PSYCHIATRY, 2010, 22 (02) : 84 - 93
  • [48] Low Doses of Melatonin to Improve Sleep in Children with ADHD: An Open-Label Trial
    Checa-Ros, Ana
    Munoz-Hoyos, Antonio
    Molina-Carballo, Antonio
    Viejo-Boyano, Iris
    Chacin, Maricarmen
    Bermudez, Valmore
    D'Marco, Luis
    CHILDREN-BASEL, 2023, 10 (07):
  • [49] Safety and effectiveness of methylphenidate ER multi-unit pellet system in ADHD patients: An open label study
    Schoeman, Renata
    Lai, Evelyn Y.
    Nel, Anne-Marie
    Gani, Mashra
    Fulat, Muhammed A.
    Mahomed, Akbar A.
    SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2024, 30
  • [50] Effects of Long Acting Methylphenidate on Ghrelin Levels in Male Children with Attention Deficit Hyperactivity Disorder: An Open Label Trial
    Yalcin, Ozhan
    Iseri, Elvan
    Bukan, Neslihan
    Ercin, Ugur
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 24 (02): : 146 - 157
12345